Closing Bell: Nifty below 24,600, Sensex down 166 pts; PSU Banks gain

Indian equity indices ended lower in the second consecutive session on August 6 with Nifty below 24,600. At close, the Sensex was down 166.26 points or 0.21 percent at 80,543.99, and the Nifty was down 75.35 points or 0.31 percent at 24,574.20.

We wrap up today's edition of the Moneycontrol live market blog, and will be back tomorrow morning with all the latest updates and alerts. Please visit https://www.moneycontrol.com/markets/global-indices for all the global market action.

Today, the benchmark indices continued with weak momentum. The Nifty ends 75 points lower, while the Sensex was down by 166 points. Among sectors, most of the leading sectoral indices registered intraday profit booking at higher levels, but the Pharma Index lost the most, shedding 2 percent. Technically, the market is still holding a lower top and, on daily charts, has created a small bearish candle, which is largely negative.

We believe that the short-term market outlook is weak but oversold. On the downside, 24,500/80300 continues to be a promising support zone, while 24,700/81000 would act as a crucial resistance area for the bulls. Above 24,700/81000, the pullback is likely to continue up to 24,850–24,900/81500-81600. Conversely, a decline below 24,500/80300 could push the market down to 24,350–24,300/80000-79700.

Rupee traded in range near 87.75 as participants see RBI POLICY as neutral event but focus remains on Trumps tariffs as higher tariffs on India as signnaled by trump which can affect the sentiment. Rupee range can be seen in 87.45-88.25.

Markets remained volatile on Wednesday and ended lower amid mixed cues. After a flat start, the Nifty oscillated within a range and eventually settled near the lower end at 24,574.20. Participants were awaiting the outcome of the MPC meeting, which was in line with expectations, as the policy rate remained unchanged and the neutral stance continued. As a result, there was no significant market reaction.

Most sectors edged lower, with pharma, IT, and realty emerging as the top losers. However, resilience in banking heavyweights helped limit the overall downside. The broader indices also came under pressure, each losing nearly a percent.

The recent price action reflects indecisiveness among market participants amid ongoing uncertainty surrounding tariffs and trade deals. Any negative surprise on this front could exert further pressure, with the next support for the Nifty placed at 24,450. On the upside, the 24,700–24,800 zone may continue to act as an immediate hurdle. Participants should align their positions accordingly, with an emphasis on stock selection and risk management.

Despite renewed trade tensions—stemming from the U.S.—the domestic market remained resilient, holding firm near the key support level of 24,500. The pharma sector underperformed, emerging as a notable casualty of the tariff warnings. As expected, the RBI maintained a neutral stance and kept policy rates unchanged, acknowledging global headwinds while emphasizing India’s domestic resilience, fiscal prudence, and strong rural demand.

The inflation outlook has turned more favourable, supported by a good monsoon and healthy kharif sowing. In anticipation of improvement in consumption, private investment, and continued government-led capex, the domestic economy appears well-positioned for a better second half, reinforcing investor confidence despite external uncertainties.

The choppy movement continued in the market on Wednesday and the RBI's mid quarter policy outcome has failed to lift the sentiment in the market, as Nifty closed the day lower by 75 points. After opening with a flat note, the market slipped into sharp weakness in the early part of the session. There was a minor recovery in the mid part and the market finally closed near the lows.

A small negative candle was formed on the daily chart which indicates a narrow range movement in Nifty over the last few sessions near the crucial support of 24500 levels. This is not a good sign and suggests that the said support could eventually be broken decisively on the downside in the near term.

The underlying trend of Nifty continues to be weak amidst choppy movement. A sharp breakdown of the support of 24500 could trigger quick decline down to the next support of 24200 levels (200day EMA). Immediate resistance placed at 24800.

Nifty remained bearish throughout the day as the index stayed under selling pressure, holding below the 50EMA throughout the session. The RSI continued to display a bearish crossover on both the daily and hourly charts. In addition, a lower-top, lower-bottom formation has developed on the hourly chart, indicating a weakening trend.

The index is likely to remain a “sell on rise” as long as it stays below 24,850. In the short term, the index may trend downwards towards 24,400, which is expected to act as a crucial support level on a sustained or closing basis. If Nifty sustains below 24,400, it is likely to witness a more serious correction.

Indian rupee ended with marginal gains at 87.73 per dollar on Wednesday versus Tuesday's close of 87.80.

Indian equity indices ended lower in the second consecutive session on August 6 with Nifty below 24,600.

At close, the Sensex was down 166.26 points or 0.21 percent at 80,543.99, and the Nifty was down 75.35 points or 0.31 percent at 24,574.20. About 1292 shares advanced, 2594 shares declined, and 144 shares unchanged.

Biggest Nifty losers were Wipro, Sun Pharma, Jio Financial, IndusInd Bank, Tech Mahindra, while gainers included Asian Paints, HDFC Life, Trent, Adani Ports and Bharat Electronics.

Except PSU Bank (up 0.6 percent), all other sectoral indices ended in the red with Information Technology, Media, Realty, Pharma, FMCG down 1-2 percent.

The BSE midcap and smallcap indices down 1 percent each.

Blue Star was quoting at Rs 1,787.60, up Rs 37.10, or 2.12 percent.

It has touched an intraday high of Rs 1,822.25 and an intraday low of Rs 1,723.00.

It was trading with volumes of 9,032 shares, compared to its five day average of 8,367 shares, an increase of 7.95 percent.

In the previous trading session, the share closed up 0.44 percent or Rs 7.65 at Rs 1,750.50.

The share touched a 52-week high of Rs 2,419.95 and a 52-week low of Rs 1,521.20 on 06 January, 2025 and 30 May, 2025, respectively.

Currently, the stock is trading 26.13 percent below its 52-week high and 17.51 percent above its 52-week low.

Market capitalisation stands at Rs 36,755.70 crore.

GlaxoSmithKline Pharmaceuticals was quoting at Rs 2,735.40, down Rs 104.90, or 3.69 percent.

It has touched an intraday high of Rs 2,849.85 and an intraday low of Rs 2,659.00.

It was trading with volumes of 12,521 shares, compared to its five day average of 3,787 shares, an increase of 230.63 percent.

It was trading with volumes of 12,521 shares, compared to its thirty day average of 2,587 shares, an increase of 384.04 percent.

In the previous trading session, the share closed down 0.87 percent or Rs 24.95 at Rs 2,840.30.

The share touched a 52-week high of Rs 3,515.95 and a 52-week low of Rs 1,924.30 on 05 June, 2025 and 03 February, 2025, respectively.

Currently, the stock is trading 22.2 percent below its 52-week high and 42.15 percent above its 52-week low.

Market capitalisation stands at Rs 46,339.33 crore.

#1 Standalone revenue grew +2 percent

#2 Decorative volume grew +5.6 percent & was impacted by early monsoons

#3 Berger continued to gain market share within 5 listed paint companies & market share improved to 21.2 percent

#4 Gradual improvement in demand expected as monsoon abates & base gets favourable

#5 Management is hopeful of 9–10 percent value growth by Q3 & Q4

#6 Company aspires to continue to grow 2–2.5 percent ahead of industry growth

#7 Competitive intensity remains elevated, but has stabilised

#8 Dealer level margins for the new entrant may have reduced due to higher inter-dealer competition

The company had received Import and Market Permission in Form CT-20 from the Drugs Controller General of India for Eculizumab concentrate for solution for infusion 300 mg (10mg/ml) (SOLIRIS).

Eculizumab (Soliris) is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic Uremic Syndrome (aHUS) to inhibit complement – mediated thrombotic microangiopathy.

#1 Cell business performance key metric to track

#2 1Q margins ahead; growth recovery remains slow

#3 Rising commodity costs a margin headwind

QIB – 6.27 times

NII - 83.94 times

Retail – 66.37 times

Overall – 64.23 times

Godrej Agrovet was quoting at Rs 837.30, up Rs 27.75, or 3.43 percent.

It has touched an intraday high of Rs 849.60 and an intraday low of Rs 804.75.

It was trading with volumes of 11,099 shares, compared to its five day average of 15,199 shares, a decrease of -26.97 percent.

In the previous trading session, the share closed down 0.22 percent or Rs 1.80 at Rs 809.55.

The share touched a 52-week high of Rs 876.30 and a 52-week low of Rs 655.00 on 24 July, 2025 and 02 May, 2025, respectively.

Currently, the stock is trading 4.45 percent below its 52-week high and 27.83 percent above its 52-week low.

Market capitalisation stands at Rs 16,101.16 crore.

#1 An upfronted start to FY26 makes DLF's management confident of meeting its Rs 220 billion pre-sales target

#2 Mumbai's well-received launch also encourages management to add more projects here

#3 Cash generation is strong and the Rs 33 are net cash will build up further

#4 P&L driver will likely shift to lease income now, as several large properties complete, while residential completions are from FY28

#1 Q1 consolidated revenue growth of 9 percent YoY, in-line

#2 Standalone business grew 9.8 percent YoY

#3 Gross margin was down 310 bps YoY and flattish QoQ at 40.3 percent

#4 EBITDA margin contracted 136 bps YoY to 16.4 percent, 80 bps below estimate

#5 Absolute EBITDA 5 percent below estimate driven by higher-than-expected employee expenses

#6 Company highlighted a marginal consumption uptick in both urban & rural markets

#7 PAT growth was flattish YoY

The Sensex was down 161.59 points or 0.20 percent at 80,548.66, and the Nifty was down 77.95 points or 0.32 percent at 24,571.60. About 1140 shares advanced, 2411 shares declined, and 118 shares unchanged.

Indian rupee is trading higher by 13 paise at 87.67 per dollar versus Tuesday's close of 87.80.

Morepen Laboratories was quoting at Rs 53.40, down Rs 3.16, or 5.59 percent.

It has touched an intraday high of Rs 57.28 and an intraday low of Rs 51.75.

It was trading with volumes of 439,974 shares, compared to its five day average of 174,356 shares, an increase of 152.34 percent.

In the previous trading session, the share closed down 2.08 percent or Rs 1.20 at Rs 56.56.

The share touched a 52-week high of Rs 100.80 and a 52-week low of Rs 41.66 on 10 September, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 47.02 percent below its 52-week high and 28.18 percent above its 52-week low.

Market capitalisation stands at Rs 2,926.07 crore.

KPIG Energia, a wholly owned subsidiary of the Company has received a Letter of Award (LOA) from Aditya Birla Renewables Limited (ABRL) for 64 MWac / 96 MWp Solar Balance of System (BoS) Power Plant at Mahua, Gujarat.

The scope of work includes Design, Engineering, procurement, supply, loading, unloading, transportation, arranging comprehensive insurance, erection, testing, synchronization, achieving Commissioning by the Schedule Commercial Operation (CoD), conducting performance acceptance test (PAT) and facility acceptance test (FAT) for Solar Project.

#1 Underlying revenues were in-line but profits missed estimates

#2 Cut estimates by 1–3 percent

#3 Expect Bharti Hexacom to deliver 24 percent/29 percent CAGRs in EBITDA/FCF over FY25–28

#4 BHL's stronger growth vs Bharti Airtel will support premium valuations

Bayer CropScience was quoting at Rs 6,006.30, down Rs 285.05, or 4.53 percent.

It has touched an intraday high of Rs 6,418.25 and an intraday low of Rs 5,993.75.

It was trading with volumes of 4,364 shares, compared to its five day average of 3,108 shares, an increase of 40.40 percent.

In the previous trading session, the share closed up 0.63 percent or Rs 39.65 at Rs 6,291.35.

The share touched a 52-week high of Rs 7,189.90 and a 52-week low of Rs 4,220.05 on 08 August, 2024 and 13 February, 2025, respectively.

Currently, the stock is trading 16.46 percent below its 52-week high and 42.33 percent above its 52-week low.

Market capitalisation stands at Rs 26,993.57 crore.

Pidilite Industries was quoting at Rs 3,035.20, up Rs 37.60, or 1.25 percent.

It has touched an intraday high of Rs 3,059.00 and an intraday low of Rs 2,970.05.

It was trading with volumes of 24,667 shares, compared to its five day average of 12,180 shares, an increase of 102.51 percent.

In the previous trading session, the share closed up 1.58 percent or Rs 46.70 at Rs 2,997.60.

The share touched a 52-week high of Rs 3,414.40 and a 52-week low of Rs 2,620.15 on 30 September, 2024 and 03 March, 2025, respectively.

Currently, the stock is trading 11.11 percent below its 52-week high and 15.84 percent above its 52-week low.

Market capitalisation stands at Rs 154,391.24 crore.

NIIT Learning Systems was quoting at Rs 323.65, down Rs 10.55, or 3.16 percent.

It has touched an intraday high of Rs 342.25 and an intraday low of Rs 328.00.

It was trading with volumes of 1,443 shares, compared to its five day average of 11,907 shares, a decrease of -87.88 percent.

In the previous trading session, the share closed up 4.60 percent or Rs 14.70 at Rs 334.20.

The share touched a 52-week high of Rs 542.00 and a 52-week low of Rs 306.50 on 25 September, 2024 and 31 July, 2025, respectively.

Currently, the stock is trading 39.3 percent below its 52-week high and 7.34 percent above its 52-week low.

Market capitalisation stands at Rs 4,508.32 crore.

#1 Gross margin at 39.2 percent down 260 bps YoY

#2 EBITDA margin was 16.7 percent vs estimate of 17.8 percent

#3 Management expects to sustain growth with continued brand investments & product innovation

#4 Managing margins owing to increased competition

EID Parry (India) was quoting at Rs 1,233.50, up Rs 41.75, or 3.50 percent.

It has touched an intraday high of Rs 1,245.20 and an intraday low of Rs 1,168.00.

It was trading with volumes of 15,501 shares, compared to its five day average of 11,507 shares, an increase of 34.71 percent.

In the previous trading session, the share closed up 0.02 percent or Rs 0.20 at Rs 1,191.75.

The share touched a 52-week high of Rs 1,246.45 and a 52-week low of Rs 639.30 on 31 July, 2025 and 03 March, 2025, respectively.

Currently, the stock is trading 1.04 percent below its 52-week high and 92.95 percent above its 52-week low.

Market capitalisation stands at Rs 21,931.15 crore.

PVR INOX was quoting at Rs 1034.35, down Rs 1.4, or 0.14 percent.

It has touched an intraday high of Rs 1,041.05 and an intraday low of Rs 1,000.50.

It was trading with volumes of 6,358 shares, compared to its five day average of 10,995 shares, a decrease of -42.17 percent.

In the previous trading session, the share closed up 1.85 percent or Rs 18.85 at Rs 1,035.75.

The share touched a 52-week high of Rs 1,748.25 and a 52-week low of Rs 825.65 on 27 September, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 42.24 percent below its 52-week high and 22.3 percent above its 52-week low.

Market capitalisation stands at Rs 9,916.23 crore.

#1 No surprise on residential segment; rentals growing at healthy pace

#2 Overall, upside risk to pre-sales guidance for FY26 at Rs 21,000 crore remains low

#3 Expect consolidated rentals at 15 percent CAGR over FY25–FY28

#1 Cement prices have surprisingly held up well amid monsoons, even in a relatively weak demand environment

#2 Channel checks indicate there was no meaningful drop in July & companies expect prices to pick up post-monsoon season

#3 Companies reiterated their expectations of 6–7 percent growth in FY26

#4 Believes hinges on a rural recovery & an uptick in government capex

#5 Overall expect industry profit pool to grow 35 percent in FY26 & at a 22 percent CAGR over FY25–28

#1 Q1FY26 weaker-than-expected

#2 Share gains in industrial expected to continue

#3 Margin contraction higher than expected due to negative operating leverage

#4 Going deeper in stronger catchments for decorative & increasing TAM in industrial

#1 Gross margin at 39.2 percent down 260 bps YoY

#2 EBITDA margin was 16.7 percent vs estimate of 17.8 percent

#3 Management expects to sustain growth with continued brand investments & product innovation

#4 Managing margins owing to increased competition

Britannia Industries was quoting at Rs 5,403.00, down Rs 228.35, or 4.05 percent.

It has touched an intraday high of Rs 5,625.00 and an intraday low of Rs 5,373.00.

It was trading with volumes of 12,368 shares, compared to its five day average of 7,819 shares, an increase of 58.18 percent.

In the previous trading session, the share closed down 2.66 percent or Rs 153.85 at Rs 5,631.35.

The share touched a 52-week high of Rs 6,473.10 and a 52-week low of Rs 4,506.50 on 03 October, 2024 and 04 March, 2025, respectively.

Currently, the stock is trading 16.53 percent below its 52-week high and 19.89 percent above its 52-week low.

Market capitalisation stands at Rs 130,141.14 crore.

QIB – 5.60 times

NII - 68.44 times

Retail – 56.59 times

Overall – 53.66 times

Indian rupee is trading 11 paise higher at 87.69 per dollar versus Tuesday's close of 87.80.

Adani Energy Solutions was quoting at Rs 792.25, down Rs 10.15, or 1.26 percent.

It has touched an intraday high of Rs 802.45 and an intraday low of Rs 780.00.

It was trading with volumes of 11,416,168 shares, compared to its five day average of 57,712 shares, an increase of 19,681.34 percent.

In the previous trading session, the share closed up 0.33 percent or Rs 2.65 at Rs 802.40.

The share touched a 52-week high of Rs 1,170.75 and a 52-week low of Rs 588.25 on 07 August, 2024 and 27 November, 2024, respectively.

Currently, the stock is trading 32.33 percent below its 52-week high and 34.68 percent above its 52-week low.

Market capitalisation stands at Rs 95,171.62 crore.

XTGlobal Infotech announced its successful award of a major IT modernization project from a prominent U.S.-based State Agency.

The IT modernization program will be executed over a five-year period and will encompass multiple sub-projects, each targeting critical backend systems and technology upgrades.

#1 Q1 impacted by an early monsoon but 5.6 percent volume growth remains market leading

#2 H2FY26 is on a low base for the overall industry

#3 Double-digit revenue growth prints could resume in Q4 for Berger

The Sensex was down 56.73 points or 0.07 percent at 80,653.52, and the Nifty was down 37.95 points or 0.15 percent at 24,611.60. About 1083 shares advanced, 2393 shares declined, and 114 shares unchanged.

UNO Minda was quoting at Rs 1,093.30, down Rs 10.10, or 0.92 percent.

It has touched an intraday high of Rs 1,111.00 and an intraday low of Rs 1,080.75.

It was trading with volumes of 23,147 shares, compared to its five day average of 14,600 shares, an increase of 58.54 percent.

In the previous trading session, the share closed up 4.00 percent or Rs 42.40 at Rs 1,103.40.

The share touched a 52-week high of Rs 1,252.85 and a 52-week low of Rs 768.10 on 02 September, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 12.73 percent below its 52-week high and 42.34 percent above its 52-week low.

Market capitalisation stands at Rs 62,812.56 crore.

#1 Q1 operationally in-line, US saw a soft quarter

#2 Management expects stronger H2 & maintained an overall mid-teens revenue growth guidance

#3 Believe Gland Pharma’s earnings have bottomed out but current valuations leave little upside

Konstelec Engineers has received a new work order worth Rs 4.13 crores (Total Estimated Contract Value) from Reliance Industries for completion of

electrical & instrumentation works at Jamnagar, Gujarat.

#1 Q1 EBITDA above estimates

#2 Led by domestic ports margin improvement & 2.0–2.9x YoY revenue rise in logistics & marine

#3 Management reiterated focus on absolute EBITDA growth

#4 Company intends to deliver end-to-end solutions vs pure volume driven growth

Sundaram-Clayton was quoting at Rs 1,965.25, up Rs 74.10, or 3.92 percent.

It has touched an intraday high of Rs 2,001.50 and an intraday low of Rs 1,860.00.

In the previous trading session, the share closed down 0.66 percent or Rs 12.60 at Rs 1,891.15.

The share touched a 52-week high of Rs 2,933.00 and a 52-week low of Rs 1,665.00 on 09 January, 2025 and 20 August, 2024, respectively.

Currently, the stock is trading 33 percent below its 52-week high and 18.03 percent above its 52-week low.

Market capitalisation stands at Rs 4,332.62 crore.

#1 Q1 miss on lower gRevlimid sales, channel destocking in the US & pricing pressure in APIs

#2 Europe was a silver lining

#3 Rising supplies from new plants to back EBITDA margin; volume-led growth outlook intact

#4 Look out for closure of announced acquisition of Lannett portfolio

#1 Q1 traffic up 11 percent YoY

#2 Company maintained its robust FY26 guidance

#3 Implying EBITDA growth of 14 percent–20 percent YoY despite a hazy global trade picture

#4 EBITDA margin rose in 1QFY26 with Price hikes, a better cargo mix & rupee depreciation

#5 Rising cash flow from operations drove FY25 leverage to a nine-year low

QIB – 5.41 times

NII - 62.60 times

Retail – 52.31 times

Overall – 49.39 times

Indian rupee is trading with marginal gains at 87.73 per dollar versus Tuesday's close of 87.80.

Steel Exchange India has announced a strategic non-binding collaboration with Vizag Profiles Logistics Pvt. Ltd. (VPL) and Hind Terminals Pvt. Ltd. (HTPL) to explore the development of a General Cargo Terminal (GCT) and a Multi-Modal Logistics Park (MMLP) in Visakhapatnam.

#1 Q1 India mobile revenue & EBITDA up 22–30 percent YoY; high FCF

#2 Leading ARPU and strong subscriber gains

#3 Homes net additions at an all-time high

#1 Net profit up 5.4% at Rs 2,096 crore vs Rs 1,988 crore, YoY

#2 Revenue up 5.5% at Rs 12,584 crore vs Rs 11,928 crore, YoY

#3 EBITDA up 2.7% at Rs 2,481 crore vs Rs 2,415 crore, YoY

#4 Margin at 19.7% vs 20.3%, YoY

Hero MotoCorp, Bajaj Auto, Trent, Divis Laboratories, Bajaj Holdings, Bharat Forge, Bharat Heavy Electricals, Blue Star, Fortis Healthcare, Jindal Stainless, Jyoti CNC Automation, Krishna Institute of Medical Sciences, Power Finance Corporation, Pidilite Industries, PVR Inox, TD Power Systems, and UNO Minda will release quarterly earnings on August 6.

#1 Profit declines 0.9 percent to Rs 327.6 crore Vs Rs 330.7 crore, YoY

#2 Revenue drops 13 percent to Rs 3,870.9 crore Vs Rs 4,450.3 crore, YoY

The RBI’s decision to hold the repo rate steady at 5.5% is in line with market expectations and signals a deliberate pause after frontloading 100 bps in cuts earlier this year. With headline inflation easing sharply June CPI at just 2.1% and core inflation remaining well anchored, the central bank is justified in maintaining a wait-and-watch approach. The policy stance remains neutral, but with a distinctly dovish tone, suggesting openness to further easing should growth or global conditions warrant it.

Importantly, the RBI continues to highlight global uncertainties, including tariff-related risks and volatile capital flows, as key watchpoints. At the same time, India’s domestic macro environment remains resilient, buoyed by strong government capex, stable rural demand, and improving liquidity conditions. However, subdued credit growth below 10% and uneven urban consumption trends are likely to keep the policy accommodative at the margins.

From a market perspective, the RBI’s tone will be viewed as growth-supportive without being reckless, especially as inflation is expected be at 3.1% for FY26. Rate-sensitive sectors such as banking, real estate, and autos could benefit from the sustained dovish backdrop.

It was trading with volumes of 3,833,723 shares, compared to its five day average of 3,655,997 shares, an increase of 4.86 percent.

In the previous trading session, the share closed down 4.80 percent or Rs 119.40 at Rs 2,367.20.

The share touched a 52-week high of Rs 3,030.00 and a 52-week low of Rs 780.63 on 10 June, 2025 and 07 August, 2024, respectively.

Currently, the stock is trading 24.32 percent below its 52-week high and 193.74 percent above its 52-week low.

Market capitalisation stands at Rs 93,125.40 crore.

The company has received Letter of Award for creation of integrated material handling facility at the Navel Dockyard in Mumbai by Military Engineer Services (MES) in Maharashtra.

HG Infra Engineering Ltd. was quoting at Rs 1,006.05, down Rs 21.15, or 2.06 percent.

It has touched an intraday high of Rs 1,036.95 and an intraday low of Rs 1,004.30.

It was trading with volumes of 3,689 shares, compared to its five day average of 4,997 shares, a decrease of -26.18 percent.

In the previous trading session, the share closed down 0.58 percent or Rs 5.95 at Rs 1,027.20.

The share touched a 52-week high of Rs 1,666.10 and a 52-week low of Rs 921.05 on 20 August, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 39.62 percent below its 52-week high and 9.23 percent above its 52-week low.

Market capitalisation stands at Rs 6,556.54 crore.

The MPC's decision to hold the repo rate steady at 5.5% hasn’t come as a surprise, as the committee has already frontloaded rate cuts earlier this year and has announced its intent to inject ample liquidity into the banking system, by way of reducing Cash Reserve Ratio (CRR). It is likely that they will continue to remain neutral and assess how effectively the earlier rate cuts are transmitting through the banking system through reduced lending rates, improved credit availability, and greater consumer confidence.

This usually takes a few months to reflect. With inflation trends easing, buoyed by a promising monsoon and healthy kharif season, we can expect a rate cut in the second half of FY25.

The Sensex was down 138.41 points or 0.17 percent at 80,571.84, and the Nifty was down 69.65 points or 0.28 percent at 24,579.90. About 986 shares advanced, 2440 shares declined, and 117 shares unchanged.

#1 Net profit up 27% at Rs 545 crore vs Rs 430 crore, YoY

#2 Revenue up 14% at Rs 2,410 crore vs Rs 2,118 crore, YoY

33 EBITDA up 16.3% at Rs 756 crore vs Rs 650 crore, YoY

#4 Margin at 31.4% vs 30.7%, YoY

Divis Laboratories was quoting at Rs 6,211.40, down Rs 197.95, or 3.09 percent.

It has touched an intraday high of Rs 6,428.50 and an intraday low of Rs 6,211.40.

It was trading with volumes of 6,182 shares, compared to its five day average of 5,359 shares, an increase of 15.37 percent.

In the previous trading session, the share closed down 1.29 percent or Rs 83.80 at Rs 6,409.35.

The share touched a 52-week high of Rs 7,077.70 and a 52-week low of Rs 4,617.10 on 08 July, 2025 and 19 August, 2024, respectively.

Currently, the stock is trading 12.24 percent below its 52-week high and 34.53 percent above its 52-week low.

Market capitalisation stands at Rs 164,893.15 crore.

#1 Profit rises 1.4 percent to Rs 72.4 crore Vs Rs 71.5 crore, YoY

#2 Revenue zooms 36.5 percent to Rs 1,055.6 crore Vs Rs 773.3 crore, YoY

The policy meeting outcome was in line with expectations regarding the repo rate. We now anticipate a 25 bps rate cut in the upcoming October meeting. Earlier, we had estimated the terminal policy rate for FY26 at 5%. However, given the sharp downward revision in RBI’s inflation forecast, we are revising our view to 4.75%.

On the trade front, the current structure of US tariffs on India could cause short-term disruptions in production and employment across key sectors like textiles and auto components. However, proactive political engagement is expected to lead to a more amicable resolution within the next 30–60 days, mitigating broader economic fallout. Simultaneously, free trade agreements with other nations are likely to compensate for some of the business lost to the US. Additionally, lower borrowing costs should boost urban consumer demand—a key driver of India’s GDP. Taken together, these factors strengthen the outlook for India’s economic growth to surpass that of FY25.

The RBI has held the repo rate steady at 5.5%, maintaining a neutral stance amid a stable economic backdrop. While inflation forecasts have been revised downward to 3.1% for the year, the central bank flagged potential year-end pressure, projecting a rise to 4.4% due to seasonal factors.

With GDP growth pegged at 6.5% and liquidity in surplus, the RBI reiterated its data-dependent approach, staying cautious yet flexible in the face of global uncertainties.

#1 Q1 weaker than expected

#2 Believe volumes grew 2 percent YoY, below forecast of 4.5 percent YoY

#3 GPM contracted by 310bp YoY to 40.3 percent, a tad below forecast of 40.8 percent

#4 Reported EBITDA growth was flat YoY

Despite sharply lowering its inflation forecast to 3.1% from 3.7% earlier, RBI’s decision to keep rates steady emanates from their focus on one-year-ahead expected inflation that’s looking comfortably above 4%, while growth in their view has held up well, despite global uncertainty. However, focusing on one-year-ahead expected inflation appears increasingly misplaced in an evolving world – particularly as the global landscape continues to shift toward a disinflationary bias in Asia.

We think going ahead downside risks to growth would be increasingly evident with new global resets and could still open up space for easing in remainder of the year, even though the Governor seems to have raised the bar higher for further easing.

Hero MotoCorp, Bajaj Auto, Trent, Divis Laboratories, Bajaj Holdings, Bharat Forge, Bharat Heavy Electricals, Blue Star, Fortis Healthcare, Jindal Stainless, Jyoti CNC Automation, Krishna Institute of Medical Sciences, Power Finance Corporation, Pidilite Industries, PVR Inox, TD Power Systems, and UNO Minda will release quarterly earnings on August 6.

#1 Q1 revenue was below estimates

#2 ARPU was Rs 246, up 2 percent QoQ/20 percent YoY

#3 BHL’s homes broadband subs addition at 54K was highest ever

#4 EBITDA was also below estimates

The Sensex was down 226.01 points or 0.28 percent at 80,484.24, and the Nifty was down 93.25 points or 0.38 percent at 24,556.30. About 983 shares advanced, 2316 shares declined, and 147 shares unchanged.